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SUMMARY 
Background: Ensuring high level of adherence to anti-retroviral medication (ARV) is a priority in treating 
people living with HIV and AIDS. Adherence in children cannot be fully studied if we do not recognize the 
involvement of primary caregivers who largely determine how well and often the ARV medication is taken. 
Objective:  To determine attitude and practices of the primary caregivers on adherence of ARV in HIV+ve 
children. 
Methods: A cross-sectional study involving primary caregivers of HIV +ve children. Interviewer administered 
questionnaires were used to collect data from 126 primary caregivers. The data was complemented with key 
informant in-depth interviews with the health workers at the Comprehensive Care Centre (CCC)   and two focus 
group discussions (FGD) of the primary caregivers. 
Setting: Kenyatta National Hospital comprehensive care centre for HIV/AIDS. 
Results: Adherence of 97.2 % to antiretroviral drugs was reported. The primary caregivers reported various 
methods they used to remind them when to give the medication e.g. clock alarms. 99.2% of the caregivers 
were aware of the ARV side effects. Out of the 126 caregivers interviewed, 96% of them recommended that 
caregivers of HIV+ve children should know their HIV Status. 
Conclusion: This study has revealed that practices and attitude of the caregivers of HIV +ve primary caregivers 
of HIV+ve children influence the ARV adherence levels.  Primary care givers are susceptible to or do suffer 
stress and HIV/AIDs Comprehensive Care Centres should consider establishment of pychosocial support 
groups. More studies and follow up especially in the rural settings for comparison with urban areas are 
recommended. 
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Introduction 
Treatment adherences have been closely correlated 
with viral suppression while non- adherence has a 
contributed to progression to AIDS [1]. Adherence is 
perceived as a significant barrier to the delivery of ARV 
therapy in sub – Saharan Africa [2] 
Lack of adherence to highly active anti-retroviral 
therapy (HAART) is considered to be one of the key 
challenges to AIDS worldwide. Estimates of average 
rates of non-adherence with ARV therapy range from 
50% to 70% in many different social cultural settings, 
and the risks associated with non-adherence are 
extensive at both individual and societal level [3] 
The factors that affect ARV adherence in children 
include: shortage of appropriate paediatric formulations, 
the unpalatability of some paediatric antiretroviral drugs 
and the dependence on a caregiver for delivery of the 
medication.   In studies conducted in South Africa and 
Ethiopia focusing on adherence in children, caregivers 
came out as one of the key factors that will determine 
adherence to ARV in children. The studies further 
demonstrated that the caregivers of African children 
have the potential to achieve adherence comparable to 
the wealthier countries if given the required support [4] 
,[5]. 
Millennium Development Goal 6, which focuses 
on combating HIV/AIDS, provides that, by 2015, 
the world will have halted and begun to reverse 
the global HIV epidemic by making the HIV 
response one of the overriding international 
priorities for the 21st century (UNAIDS, 2008). 
 
Sub-Saharan Africa remains the most heavily affected 
region in global HIV epidemic with 23.5 million people 
living with HIV residing in sub-saharan Africa which 
represents 69% of global HIV burden [6]. An estimated 
3.4 million children were living with HIV at the end of 
2011, 91% of them in sub-Saharan Africa [6]. HIV is 
the underlying reason for more than one third of all 
deaths among children under the age of five [7].New 
infections in children dropped by 43% from 2003 to 
2011[8].This decline mainly reflects the drop in new 
infections in children as well as increased access to 
antiretroviral treatment. Research has shown that non-
adherence to prescribed regimens is common, whether 
the disease is acute, chronic or whether the patient 
population is adult or pediatric [9]. The major factor 
determining the success of ARV is sustainable and 
optimum adherence to therapy [10]. 
As of December 2011, there were 1.6 million people 
living with HIV/AIDS in Kenya. The adult HIV 
prevalence in Kenya as of 2010 was 6.2% with women 
representing 58% of the prevalence among adults [11]. 
In 2011, 220,000 children between the age of 0-14 
years in Kenya were estimated to be living with 
HIV/AIDS and there were an estimated 1.1 million 
AIDS orphans between the age of 0-17 years  [8].The 
access to ARV in Kenya has improved over time with 
83.1% of adults eligible for ARV receiving the 
medication. The access to ARV for children has been 
challenging in Kenya with only 31.1% of those eligible 
for ARV receiving it [11]. Adherence to ARV has been 
found to predict HIV clinical outcome [12]. Pediatric 
adherence to ARV is not well studied in resource-
limited settings. Unlike adults, children are relatively 
more dependent on others for their well being and care. 
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It is therefore important to understand the perspective 
of the caregivers for the HIV-infected children and its 
effect on adherence to ARV. 
 
Materials and Methods 
Study Design: A cross-sectional descriptive study 
involving both qualitative and quantitative research 
methods was conducted among primary caregiver of 
HIV +Ve children attending the HIV/AIDS 
Comprehensive care Centre (CCC) at Kenyatta 
National Hospital.  
Sampling: The systematic sampling method was be 
used for the primary caregivers attending the Kenyatta 
hospital CCC. In 2010 Kenyatta Hospital had 
approximately 700 children enrolled for ARV with an 
average attendance of 15 – 20 patients per day. The 
Sample size for the study was 126. Sample size 
determination was based on the facts according to  the 
UNAIDS report 2008 there were 2 million people in 
Kenya living with HIV / AIDS, of these 180,000 were 
children which is 9% of the total population living with 
HIV/AIDS. The proportions to be used in the sample 
size calculations were 9% (UNAIDS WHO 2008).  
Inclusion criteria: The primary caregivers must have 
been fully involved in the day to day care of the HIV-
infected children between the ages of 2-12 years  
The primary caregiver must have spent at least the 6 
months prior to the interview date caring for the child 
and attending that particular CCC. Those participants 
who gave written consent were the only ones allowed 
to participate in the study.  
Exclusion criteria: Primary caregivers who did not 
consent to participate in the study or those who 
withdrew the consent during the interview. Pre-testing 
of the questionnaire was done at Kenyatta National 
Hospital. The questionnaires were analyzed and any 
corrections or adjustments were made to the data 
collection tool. Those who participated in the pre-
testing were not being eligible for the actual research. 
Their card numbers were recorded to ensure that they 
were skipped during the actual research. 
Ethical considerations: Clearance was obtained from 
the Scientific Steering Committee and the National 
Ethical Review Committee. Informed consent from the 
study subjects was obtained. Study subjects 
confidentiality was maintained by not including their 
names on the questionnaire. 
Those who declined to participate had their wish 
respected and this did not affect their services in the 
clinic. There was no direct benefit to the study 
participants but the information collected was analyzed 
and the findings will be shared with donors and the 
ministry of health for the purpose of improving policies 
and activities that will enhance the ARV therapy in 
children. The study participants were not exposed to 
any invasive clinical procedures. 
Results 
The Mean age of the respondents was 38 years and 5 
months (age raging from 18 – 65 years). The majority 
of the caregivers were between age 20 and 55 years 
which accounted for 96.9%. Out of the 126 
respondents, 84.1% were women and 15.9% men. Of 
the caregivers interviewed, 99.2% said that they gave 
children the ARV medications at the same time every 
day. The caregiver reported various methods they used 
to remind them when to give the medication e.g. Wall 
clocks, alarms mobile phone and radios. The 
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knowledge level on   adverse effects of the ARV 
medications was high (98%) with the majority of the 
caregivers (99.2%) aware of the ARV side effects. 
97.6% of the caregivers interviewed were convinced 
that the ARV is effective and that the ARVs had helped 
to improve the quality of life of the children and also 
prolong their life span. Despite the various challenges 
in administration of the ARV the adherence levels 
remained high (97.2%). Most respondents (72.2%) felt 
that the children they are taking care of have a right to 
know their HIV status, 21.4% felt that they should not 
be told and the remainder (6.3%) did not know what to 
do. Majority of the caregivers (96%) thought it was 
important for caregivers to know their own HIV status. 
 
Table 1: Number of times caregivers missed to give 
ARV 
 
Number of caregivers 
who have not missed 
doses 
Proportion ( out of 126 
caregivers interviewed) 
In the last 72 hours 95.2% 
Last week 4% 
Last two weeks 0.8% 
 
Table 2: ARV effective, caregivers’ perspective 
Opinion on 
effectiveness of 
ARV 
Frequency  Percentage 
They are effective 123 97.6% 
They are not 
effective 
0 0% 
I do know 3 2.4% 
Figure 1: Attitude towards knowledge on the HIV 
status of the caregiver and the child being cared for 
 
 
 
Discussion:  
In this study the attitude and practices of caregivers 
were seen to greatly influence the adherence levels to 
ARV in children. The Study found that adherence to 
ARV was high i.e. 97.2 % as reported by the 
interviewed care givers and confirmed during the focus 
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group discussion. Additionally, in a study conducted in 
Uganda supported the fact that the caregivers play 
major role in establishing a medication taking routine 
which contributes to adherence to ARV [13].  
Over 65% of the caregivers had education level above 
secondary and had some form of employment (formal 
and self-employed). This could be attributed to the fact 
that this study was done in an urban setting. Majority of 
the respondents were very knowledgeable on the times 
the ARV medications were to be taken and also the 
right combinations. 99.2% of the caregivers said that 
they gave children the ARV medications at the same 
time every day. The caregiver reported various 
methods they used to remind them when to give the 
medication e.g. Wall clocks, alarms mobile phone and 
radios. A study in Cape Town South Africa found that 
most (74.7%) caregivers used at least one method to 
assist with remembering and giving medication [4]. The 
most commonly used aids were activities of daily living 
reminders (40%) and treatment partners (26%). In a 
study carried out in USA on barriers to ARV adherence 
in HIV infected children and youth, forgetting to take 
medication was most commonly reported barrier to ARV 
adherence (41% for children and 33% for caregivers) 
[14]. Therefore the use of various methods/equipments 
to ensure that ARV medication is taken the right time is 
very important. 
The key informants reported that in some instances 
they had challenges with multiple caregivers which were 
experienced mainly with children in orphanage homes. 
This situation was also reported in a study in Kwa-Zulu 
Natal that there is confusion between multiple 
caregivers when it comes to ARV drug adherence [15] 
The knowledge level on   adverse effects of the ARV 
medications was high (98%) on the interviewed primary 
caregivers. 99.2% of the caregivers said that in the 
event of ARV adverse effects, they would take the child 
to hospital for review. The majority of caregivers in this 
study (72.2%) felt that the children they were taking 
care of had a right to know their HIV status. They felt 
that once the child is old enough to question or 
comprehend their HIV status then they should be 
counseled and taught gradually about their condition, to 
understand the issue of adherence and the importance 
of medication in their lives. A study conducted in 
Zambia found that there was improved adherence with 
HIV status disclosure to the child, full understanding of 
HIV medication is important to these children [16]. In 
this study at Kenyatta National Hospital, over 96% of 
the respondents recommended that caregivers should 
know their HIV status. This was also supported by the 
key informants who said that the caregivers need to 
know their HIV status so that they can take appropriate 
steps as they care for the HIV +ve children. The key 
informants emphasized that when the care givers know 
their status it reduces stigma to child. In a study 
conducted in Cape Town South Africa it was 
recognized that stigma surrounding HIV can also lead 
to adherence problems if parents and caregivers are 
unwilling to make it publicly known that the child in their 
care is HIV-positive [4]. In another Study conducted in 
Uganda it was found that children whose caregivers 
had possible depression and were ashamed of their 
child’s HIV status had poor adherence levels [13].  
In this study majority of the caregivers believed that HIV 
positive caregivers are better suited to provide better 
care to HIV positive children because they are going 
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through the same thing or experience. Similar findings 
were  reported in a study conducted in Uganda that 
caregivers taking ARV themselves may have 
established effective means for adherence, which can 
be passed on to the children[13]. Another study at 
Sinikithemba HIV/AIDS Clinic, McCord Hospital, 
Durban, South Africa showed  that more than half of 
the HIV +ve children in the Sinikithemba cohort are 
cared for by at least one HIV-positive caregiver, these 
caregivers showed a protective effect against mortality 
in HIV +ve when compared with caregivers who were 
untested or HIV negative[15]. 
In order for the caregivers to succeed in continually 
supporting children on adhering to their medications, 
this study found that the primary caregivers needed 
social-economic support to help them improve their 
quality of life. Similar findings were also seen in a study 
of the Sinikithemba cohort in Durban South Africa [15] 
where adherence issues could put an enormous strain 
on the daily lives of parents and caregivers who are 
usually responsible for administering treatment. 
Additionally this study   found that even though the cost 
of providing ARV drugs is theoretically free (covered by 
government and donor sources), potential clients still 
have to find money to pay for the high costs of 
transport, and drugs to treat opportunistic infections, in 
addition to the opportunity costs of time spent seeking 
care instead of earning money to feed and support 
other household members. Majority of the caregivers 
interviewed were convinced that the ARV is effective 
and that the ARVs had helped to improve the quality of 
life of the children and also prolong their life span. 96% 
the caregivers stated that it was important know their 
HIV status and 90.4% agreed that the HIV status of the 
caregiver influences the way they care for the HIV+ve 
children. 
The caregivers were also aware of the appropriate 
actions to take when adverse drug reaction is 
suspected. Despite the various challenges in 
administration of the ARV the adherence levels 
remained high (97.2%). In case of adverse effects like 
vomiting, primary caregivers reported that they gave a 
repeat doze after 30 minutes. Also the challenge of 
cold storage of some forms of ARV was addressed by 
keeping the ARV medications that required cold storage 
in water. The caregivers were also aware of the 
appropriate actions to take when adverse drug reaction 
is suspected.  
In this study, conducted at Kenyatta National Hospital, 
the caregivers advocated for more supportive 
counseling, spiritual and social support to help them 
cope with and manage the challenges that come with 
caring for a HIV+ve child. This support should include 
more knowledge on ARV, adherence, nutrition and any 
other issues dealing with ARV care for HIV positive 
children.  Comprehensive treatment literacy for the 
caregivers is very important and impacts on adherence 
to ARV Key informants in this study (KNH CCC) noted 
that little has been done on developing educational 
materials like pamphlets, educational aid materials, and 
take-home booklets related to ARV in children. 
The importance of joining or belonging to a support 
group both in the hospital and outside the hospital 
setting was affirmed by an overwhelming majority 
(92.9%) of the primary caregivers for psychosocial 
support. This was also supported by the key informants 
and focus group discussion informants who agreed that 
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support groups are avenues to release stress and 
forums to talk about experiences and challenges. In 
these support groups the members can also benefit 
from others by getting knowledge on how to undertake 
income generating activities. In study conducted in 
South Africa [17] community-based adherence support 
was seen be an effective way to improve patient 
retention amongst children receiving ART in low-
income setting. Support groups at Kenyatta National 
Hospital are short term and are set up for the purpose 
of research and disbanded once the particular research 
is over.  
Key limitation to this study was the fact that this was 
done in the urban area (Nairobi city) and there is no 
comparison data for rural setting. Health workers 
supported data collection and this may have skewed 
the data to the high levels of adherence. Nevertheless, 
adherence levels to ART in Sub-Saharan Africa have 
been found to be present adequate median to ART for 
viral suppression [13]. 
  
Conclusion 
This study has revealed that practices and attitude of 
the caregivers of HIV +ve primary caregivers of HIV+ve 
children influence the ARV adherence levels. The 
appreciation by the caregivers that ARV medication 
prolongs life and improved quality of life of the children 
greatly contributed to the high level of adherence. The 
caregivers ensure that they put in place measures to 
remind them when to administer medication is very 
important to ensuring adherence. Majority of the 
caregivers were aware of the ARV side effects and took 
the children to hospital when any of those side effects 
were observed. The access to ARV has greatly 
improved due to the attention by the Ministry of Health 
and Non-governmental organizations. Support for the 
caregivers of HIV+ve children has not been prioritized 
and therefore there is need to focus on caregivers’ 
inorder to achieve high adherence levels. 
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